Brokerages Set Addus HomeCare Co. (NASDAQ:ADUS) Target Price at $110.50

Posted by Defense World Staff on Sep 17th, 2023

Shares of Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) have been given a consensus recommendation of “Buy” by the four analysts that are covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have covered the stock in the last year is $110.50.

A number of research analysts have recently commented on ADUS shares. Stephens upped their price target on Addus HomeCare from $100.00 to $110.00 and gave the stock an “overweight” rating in a report on Wednesday, August 2nd. Oppenheimer restated an “outperform” rating and issued a $118.00 target price on shares of Addus HomeCare in a research note on Wednesday, August 2nd. Raymond James upped their target price on Addus HomeCare from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, August 2nd. StockNews.com upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 5th. Finally, TheStreet lowered Addus HomeCare from a “b-” rating to a “c+” rating in a research note on Wednesday.

View Our Latest Research Report on Addus HomeCare

Insider Activity at Addus HomeCare

In other news, COO W Bradley Bickham sold 5,000 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $93.85, for a total transaction of $469,250.00. Following the completion of the sale, the chief operating officer now directly owns 38,285 shares in the company, valued at approximately $3,593,047.25. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Addus HomeCare news, COO W Bradley Bickham sold 5,000 shares of the company’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $93.85, for a total value of $469,250.00. Following the completion of the transaction, the chief operating officer now owns 38,285 shares of the company’s stock, valued at approximately $3,593,047.25. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO R Dirk Allison sold 24,922 shares of the company’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $94.39, for a total value of $2,352,387.58. Following the completion of the transaction, the chief executive officer now directly owns 52,850 shares of the company’s stock, valued at approximately $4,988,511.50. The disclosure for this sale can be found here. Insiders sold 34,812 shares of company stock worth $3,279,405 in the last ninety days. 4.40% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of ADUS. Macquarie Group Ltd. boosted its stake in Addus HomeCare by 84.0% during the fourth quarter. Macquarie Group Ltd. now owns 287 shares of the company’s stock valued at $29,000 after buying an additional 131 shares during the period. Lazard Asset Management LLC purchased a new position in shares of Addus HomeCare in the fourth quarter worth about $30,000. Pinebridge Investments L.P. purchased a new position in shares of Addus HomeCare in the second quarter worth about $41,000. Point72 Hong Kong Ltd purchased a new position in Addus HomeCare during the 2nd quarter valued at about $41,000. Finally, Tower Research Capital LLC TRC increased its holdings in Addus HomeCare by 62.1% during the 1st quarter. Tower Research Capital LLC TRC now owns 457 shares of the company’s stock valued at $49,000 after purchasing an additional 175 shares during the period. 95.26% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $83.62 on Thursday. The firm’s 50-day simple moving average is $89.91 and its 200 day simple moving average is $94.37. The stock has a market cap of $1.35 billion, a P/E ratio of 25.26, a P/E/G ratio of 1.79 and a beta of 0.86. Addus HomeCare has a fifty-two week low of $77.30 and a fifty-two week high of $114.99. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.12.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, July 31st. The company reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.07. Addus HomeCare had a return on equity of 9.06% and a net margin of 5.39%. The company had revenue of $259.98 million for the quarter, compared to analysts’ expectations of $255.56 million. Equities analysts expect that Addus HomeCare will post 3.74 EPS for the current year.

About Addus HomeCare

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.